Exploring the views of medical practitioners on proposed legislative changes in Western Australia to support supervised pharmacist prescribing in the hospital setting
Rachel Thorson BPharm, PGDipClinPharm, Barry Jenkins BPharm
{"title":"Exploring the views of medical practitioners on proposed legislative changes in Western Australia to support supervised pharmacist prescribing in the hospital setting","authors":"Rachel Thorson BPharm, PGDipClinPharm, Barry Jenkins BPharm","doi":"10.1002/jppr.70026","DOIUrl":null,"url":null,"abstract":"<p>Supervised pharmacist prescribing (SPP) in the hospital setting, also known as Partnered Pharmacist Medication Prescribing (PPMP), represents a collaborative model of non-medical prescribing which could enable additional gains in efficiency, safety, and increased health service capacity. Following successful implementation of Partnered Pharmacist Medication Charting (PPMC) within our 783-bed quaternary metropolitan hospital, located in Western Australia, Australia, approximately 1800 medical practitioners were invited to complete a five-question survey via email to ascertain whether implementing SPP would be supported and thought to add value. There were 262 responses received within a two-week period, with 77.8% of doctors indicating they felt SPP would be beneficial to their team/the hospital. The Pharmacy Board of Australia previously concluded pharmacist prescribing within a collaborative healthcare environment fell within the current scope of pharmacist practice and that there were no regulatory barriers under national law. Our proposed model of SPP aligns with the Australian Medical Association's position on non-medical prescribing and recommendations in the Western Australian Sustainable health review. This project was exempt due to the local policy requirements that constitute research by the South Metropolitan Health Service Human Research Ethics Committee and registered as a quality improvement project in WA Health Governance, Evidence, Knowledge, Outcomes (Reference no: GEKO48966). The justification for this exemption was as follows: the project presented minimal patient risk and conforms with the National Health and Medical Research Council's <i>Ethical considerations in quality assistance and evaluation activities</i>. Informed consent was obtained from all participants. Potential participants were given project information via email indicating their participation was voluntary and anonymous. Participants provided their consent by completing the survey.</p>","PeriodicalId":16795,"journal":{"name":"Journal of Pharmacy Practice and Research","volume":"55 5","pages":"436-440"},"PeriodicalIF":1.0000,"publicationDate":"2025-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jppr.70026","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmacy Practice and Research","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jppr.70026","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Supervised pharmacist prescribing (SPP) in the hospital setting, also known as Partnered Pharmacist Medication Prescribing (PPMP), represents a collaborative model of non-medical prescribing which could enable additional gains in efficiency, safety, and increased health service capacity. Following successful implementation of Partnered Pharmacist Medication Charting (PPMC) within our 783-bed quaternary metropolitan hospital, located in Western Australia, Australia, approximately 1800 medical practitioners were invited to complete a five-question survey via email to ascertain whether implementing SPP would be supported and thought to add value. There were 262 responses received within a two-week period, with 77.8% of doctors indicating they felt SPP would be beneficial to their team/the hospital. The Pharmacy Board of Australia previously concluded pharmacist prescribing within a collaborative healthcare environment fell within the current scope of pharmacist practice and that there were no regulatory barriers under national law. Our proposed model of SPP aligns with the Australian Medical Association's position on non-medical prescribing and recommendations in the Western Australian Sustainable health review. This project was exempt due to the local policy requirements that constitute research by the South Metropolitan Health Service Human Research Ethics Committee and registered as a quality improvement project in WA Health Governance, Evidence, Knowledge, Outcomes (Reference no: GEKO48966). The justification for this exemption was as follows: the project presented minimal patient risk and conforms with the National Health and Medical Research Council's Ethical considerations in quality assistance and evaluation activities. Informed consent was obtained from all participants. Potential participants were given project information via email indicating their participation was voluntary and anonymous. Participants provided their consent by completing the survey.
期刊介绍:
The purpose of this document is to describe the structure, function and operations of the Journal of Pharmacy Practice and Research, the official journal of the Society of Hospital Pharmacists of Australia (SHPA). It is owned, published by and copyrighted to SHPA. However, the Journal is to some extent unique within SHPA in that it ‘…has complete editorial freedom in terms of content and is not under the direction of the Society or its Council in such matters…’. This statement, originally based on a Role Statement for the Editor-in-Chief 1993, is also based on the definition of ‘editorial independence’ from the World Association of Medical Editors and adopted by the International Committee of Medical Journal Editors.